1st Quarter - Report
THE D MAJOR GROUP for ALLERGAN INC (FORMERLY ACTAVIS INC )
Firm
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitor inter partes reform proposals, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Comt. |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Health Issues HCR
Engage with policymakers on pharmaceutical pricing matters, including international reference proposals. Promote industry best practices and highlight product advancements in the area of women's health care and ophthalmology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Analyst for the Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for the House Republican Conference |
Budget/Appropriations BUD
Advocate for adequate FDA funding for the oversight of counterfeit medicines and other product integrity issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.